Sie sind hier:
Background information on oncology for journalists.
Background information on infectious diseases for journalists.
Background information on immunology for journalists.
Roche Neuroscience is developing medicines for a range of serious brain diseases, including schizophrenia, Alzheimer's disease, multiple sclerosis, depression, Parkinson's disease, Down syndrome and autism.
We assess emerging technologies and quickly adopt the ones that can enhance our research efforts in finding new drugs and better diagnostic tests.